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Women’s Hospital, Boston, MassachusettsABSTRACT To locate the biosensor peptide DPc10 bound to ryanodine receptor (RyR) Ca2þ channels, we developed an
approach that combines fluorescence resonance energy transfer (FRET), simulated-annealing, cryo-electron microscopy,
and crystallographic data. DPc10 is identical to the 2460–2495 segment within the cardiac muscle RyR isoform (RyR2) central
domain. DPc10 binding to RyR2 results in a pathologically elevated Ca2þ leak by destabilizing key interactions between the
RyR2 N-terminal and central domains (unzipping). To localize the DPc10 binding site within RyR2, we measured FRET between
five single-cysteine variants of the FK506-binding protein (FKBP) labeled with a donor probe, and DPc10 labeled with an
acceptor probe (A-DPc10). Effective donor positions were calculated from simulated-annealing constrained by both the RyR
cryo-EM map and the FKBP atomic structure docked to the RyR. FRET to A-DPc10 was measured in permeabilized cardiomyo-
cytes via confocal microscopy, converted to distances, and used to trilaterate the acceptor locus within RyR. Additional FRET
measurements between donor-labeled calmodulin and A-DPc10 were used to constrain the trilaterations. Results locate the
DPc10 probe within RyR domain 3, ~35 A˚ from the previously docked N-terminal domain crystal structure. This multiscale
approach may be useful in mapping other RyR sites of mechanistic interest within FRET range of FKBP.INTRODUCTIONMuscle contraction is triggered by a massive release of
Ca2þ, via activation of the ryanodine receptor (RyR) Ca2þ
channels embedded in the sarcoplasmic reticulum mem-
brane. RyR isoforms expressed in skeletal (RyR1) and
cardiac (RyR2) muscle are key components of the exci-
tation-contraction coupling mechanism in these tissues
(1,2). Elevated Ca2þ leak through dysfunctional RyRs re-
sults in several widely spread pathologies characterized by
abnormally high cytosolic [Ca2þ] (3).
The 2.3 MDa RyRs are the largest ion channels identified
in natural membranes, and they consist of tetrameric assem-
blies of identical protomers (~5000 amino acids each) pre-
senting an enormous domain to the cytosol that extends
>100 A˚ from the small transmembrane (TM) domain. The
channel function residing within the RyR TM-domain is
regulated via long-range conformational changes from the
RyR cytosolic domain resulting from binding of cellular
modulators, such as Ca2þ, Mg2þ, and ATP, or small
accessory proteins like the ~12 kDa FK506 binding proteins
(FKBP, isoforms 12.0 and 12.6) or calmodulin (CaM) (4,5).
Cryo-electron microscopy (cryo-EM) three-dimensional
reconstructions at ~10 A˚ resolution have revealed impor-
tant information about the structural domains of RyR1,
including some structure-function correlations (6), althoughSubmitted June 25, 2014, and accepted for publication September 19, 2014.
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to discern. Thus far, some of these structural elements
have been deduced based on computational secondary struc-
ture prediction (7,8) and docking of partial atomic structures
into the cryo-EM map (9–11). Significant research efforts
are currently devoted to locating channel regulatory sites
in the RyR three-dimensional map (12).
FKBP12.6 binds tightly to both the skeletal and cardiac
channel isoforms (RyR1 and RyR2, respectively), and be-
haves essentially as a constitutive RyR subunit (13). A den-
sity corresponding to FKBP is clearly resolved in the RyR
cryo-EM map, and the atomic structure of FKBP has been
docked in this density (14). Using fluorescence resonance
energy transfer (FRET), we have previously shown that
FKBP12.0 and 12.6 bind at equivalent locations and orien-
tations within the RyR1 and RyR2 complexes (15). These
characteristics of the FKBP-RyR interaction have enabled
the placing fluorescent probes at precisely determined loca-
tions within the RyR three-dimensional structure, for use as
FRET donors in studies aiming to correlate RyR structural
and functional information (13,16).
A prominent working model postulates that in the resting
RyR2, there is a tight interaction (domain zipping) between
an N-terminal 150 kDa domain (17,18) (which includes
the docked ABC-domain (9)) and a central domain
(residues 2000–2500). Although this theory may be an over-
simplification, pathophysiological RyR leaky states have
been connected to weakened or disrupted physical contactshttp://dx.doi.org/10.1016/j.bpj.2014.09.029
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FIGURE 1 Crystal structure of FKBP and predicted molecular structure
of DPc10 showing the labeling sites for the FRET probes (red). Chemical
structures of the FRET probes AF488 and HF647 are shown as indicated.
To see this figure in color, go online.
2038 Svensson et al.between these two domains (domain unzipping), caused by
RyR disease-linked mutations or abnormal intracellular
conditions (19–22). Conversely, inhibitors of the RyR under
resting-state conditions also restore tight domain-domain
interactions (zipping) (19,23–25). A 36-residue domain-
peptide (DPc10), with the same sequence as residues
2460–2495 of the RyR2 central domain, induces a patholog-
ically leaky RyR2 state, and is one of the molecular tools
that have been used to develop the zipping-unzipping theory
(18). We have shown that a fluorescent DPc10 derivative
used as FRET acceptor (A-DPc10) can be an accurate
biosensor of the RyR2 functional state (26). Using FRET
to A-DPc10 from donor-labeled FKBP (D-FKBP) or CaM
(D-CaM), we have found that DPc10 binds at a sterically
restricted RyR2 site. We ruled out a previously proposed
location of this site in the ‘‘clamp’’, and deduced that it
must lie within, or close to, the ‘‘handle’’ (domain 3),
flanked by FKBP and CaM. Whereas we detected no signif-
icant cross-talk between DPc10 and FKBP binding to RyR2,
we found reciprocal allosteric inhibition between DPc10
and CaM binding to RyR2 (26).
To localize the DPc10 binding site, and possibly the N-ter-
minal domain zipping interface, within the RyR cryo-EM
map, we have conducted detailed confocal FRET studies in
cardiac myocytes. We hypothesized that, by using multiple
distance measurements from different known spatial coordi-
nates, it is possible to resolve the location of DPc10 on the
RyR cryo-EM map using a method termed ‘‘trilateration’’
(although ‘‘triangulation’’ has been casually used to indicate
the same process). We developed a computationally efficient
protocol for simulated-annealing calculations (with con-
straints from the RyR1 cryo-EM map and FKBP atomic
structure) to determine the effective coordinates of donors
attached at different sites within FKBP. A set of distances
derived from confocal FRET measurements were then used
to determine the location of the A-DPc10 probe, and thus
infer the position of a modulatory interface within RyR2.MATERIALS AND METHODS
Protein expression and labeling
Single-Cys mutants of FKBP12.6 and CaM were expressed and purified as
previously described in Cornea et al. (15). Alexa Fluor 488 C5 maleimide
(AF488; Invitrogen, Carlsbad, CA) was reacted to single Cys introduced by
site-directed mutagenesis at residues 14, 32, 44, 49, or 85 of the C22A/C76I
variant of the human isoform of FKBP12.6 (Fig. 1). These AF488-labeled
FKBPs were used as FRET donors (denoted D-FKBP, or D14-, D32-, D44-,
D49-, and D85-FKBP, respectively, to indicate the donor’s location within
FKBP) (27). AF488 was reacted to a CaMmutant containing a single Cys at
position 34, and used as FRET donor (denoted D34-CaM). Alexa Fluor 568
C5 maleimide (AF568) was reacted to a CaM mutant containing a single
Cys at position 110, and then used as FRET donor (D110-CaM). We
have previously shown that labeling at these sites does not significantly alter
binding relative to unlabeled controls (15). DPc10 peptides either unla-
beled, or labeled with HiLyte Fluor 647 (HF647) were synthesized at AnaS-
pec (Fremont, CA), and used as FRETacceptors (A-DPc10), as described in
Oda et al. (26). The molecular model of DPc10 (Fig. 1), sequenceBiophysical Journal 107(9) 2037–20482460-GFCPDHKAAMVLFLDRVYGIEVQDFLLHLLEVGFLP-2495 was
generated by the HHPred structure prediction server (28). Full-length
RyR cDNA constructs, each containing a His10 tag inserted at a specific
position within the N-terminal ABC-domain of RyR1, were created as pre-
viously described in Girgenrath et al. (27).FRET imaging
FRET measurements within RyR1 constructs expressed in HEK-293T
(HEK) cells were conducted using procedures we recently described in
Girgenrath et al. (27). HEK cells were permeabilized and imaged in
125 mM NaCl, 5 mM KCl, 6 mM glucose, 25 mM HEPES (pH 7.6),
0.1% saponin, 3 mM Cy3NTA, and 10 nM D-FKBP. FRET within native
RyR2 was measured in isolated rat ventricular myocytes, isolated, and per-
meabilized as previously described in Oda et al. (26). All procedures were
performed according to the Guiding Principles in the Care and Use of
Animals, approved by the Council of the American Physiological
Society (Bethesda, MD). Confocal imaging of permeabilized myocytes
and FRET between D-FKBPs, or D-CaMs, and A-DPc10 was measured
in a Olympus FV1000 confocal microscope (Olympus, Center Valley,
PA) equipped with Argon and Green HeNe lasers. AF488 donor was
excited with the 488 nm laser, and donor fluorescence was recorded
through a 500–530 nm bandpass filter. AF568 donor was excited at
543 nm, and donor fluorescence was detected through a 560–620 nm
bandpass filter. HF647 acceptor fluorescence was recorded through a
660–760 nm bandpass filter.
FRET Trilateration of DPc10 within Functional RyR2 2039Acceptor photobleach was performed using a 652-nm laser. Media con-
tained 1 mM EGTA, 10 mM HEPES, 120 mM potassium aspartate, 5 mM
ATP, 1 mM MgCl2, and 10 mM GSH, with CaCl2 added to obtain 30 nM
free Ca2þ (calculated using the software MAXCHELATOR, Stanford Uni-
versity, Stanford, CA; http://maxchelator.stanford.edu/), 10 mM phospho-
creatine, 5 I.U./mL creatine phosphokinase, and 4% dextran (Mr 40,000),
at pH 7.2. Fluorescently labeled FKBP, CaM, and DPc10 were added to
the bath at the indicated concentrations (26). FRET was measured using
both the donor quenching and the acceptor photobleaching methods, as pre-
viously described in Oda et al. (26) and Guo et al. (29). The FRET effi-
ciency was calculated according to
E ¼ 1 ðFDA=FDÞ; (1)
where FD and FDA are the fluorescence intensities of donor-only and donor-
acceptor samples in the donor quenching measurement, respectively, andE ¼ 1 FDpreFDpost; (2)
where FDpre and FDpost are the fluorescence intensities before and afteracceptor photobleaching, respectively. From E, we calculated donor-
acceptor using
R ¼ R0

E1  11=6; (3)
where R0 is, by definition, the distance at which E ¼ 0.5, and is calculated
from
R0 ¼ 9780

Jk2n4 fD
1=6
; (4)
where n is the refractive index (for a protein in aqueous solution, n ¼
1.4), k2 is the orientation factor (k2 ¼ 2/ when random orientation3
can be assumed), and fD is the fluorescence quantum yield of the donor
(fD(AF488) ¼ 0.92 (30)). J is the normalized spectral-overlap integral of
donor emission FD(l) and acceptor absorbance ε(l) spectra, and was calcu-
lated from
J ¼
Z
FDðlÞ εðlÞ l4dl
Z
FDðlÞdl; (5)
by numerical integration using a Microcal ORIGIN template (OriginLab,
Northampton, MA; http://www.originlab.com/). For the AF488-HF647donor-acceptor pair, we used εHF647(652 nm) ¼ 250,000 (mol1 cm1) to
calculate R0 ¼ 54 A˚.Docking of FKBP into the RyR1 EM map
The atomic structure of FKBP12 (Protein Data Bank (PDB) PDB:1D6O
(31)) was docked to the cryo-EM reconstruction of the closed state of
RyR1 (EMDB:1606 (6)). This was achieved by manually placing the struc-
tures in the RyR1 map at positions previously published in Samso´ et al.
(14), then fitting in the density using the ‘‘Fit in Map’’ function of the soft-
ware UCSF CHIMERA (University of California at San Francisco, San
Francisco, CA; https://www.cgl.ucsf.edu/chimera/) (32). The fit was opti-
mized for correlation with a map simulated from the FKBP coordinates
using the same resolution as the RyR map, i.e., 10.2 A˚. All other settings
were as default.Selection of EM map coordinates around FKBP
The CHIMERA Segment Map tool (33) was used to select the map region
corresponding to the FKBP density and to subtract that selected region from
the closed RyR EMmap. The grid points of the new map without the FKBP
density were converted to dummy atoms in a PDB file using the softwarepackage VOL2PDB program from the SITUS software package (Old
Dominion University, Norfolk, VA; http://situs.biomachina.org/) (34).
Dummy atoms within 30 A˚ from FKBP were used to restrict the conforma-
tional space of the fluorescent probe.Donor parameters for simulation with CNS
A model for AF488 was built using GAUSSVIEW 5 and geometry-opti-
mized using GAUSSIAN 09 (Gaussian, Wallingford, CT; http://www.
gaussian.com/) at the HF/6-31þg* level of theory. This model was used
with XPLO2D (Uppsala Software Factory, Uppsala University, Uppsala,
Sweden; http://xray.bmc.uu.se/usf/xplo2d_man.html) (35) to generate
topology and parameter files needed for simulations with the software
CRYSTALLOGRAPHY & NMR SYSTEM 1.3 (CNS) (Stanford Univer-
sity, Stanford, CA; http//cns-online.org/) (36,37). To allow the probe to
move more freely, the XPLO2D energy parameter for the torsional rotation
in the linker region was lowered from the default value of 750 kcal/mol to
2 kcal/mol, which is the standard CNS parameter for the methylene linkage.
The maleimide linkage to cysteine was adopted from the CNS dyes topol-
ogy and parameter files (38,39).Determining the fluorophore average position by
simulated annealing
In the atomic structure of FKBP12, the five residues at position 14, 32,
44, 49, and 85 that were used for probe attachment in the fluorescence
experiments were mutated to Cys using DISCOVERY STUDIO
VISUALIZER (Accelrys, San Diego, CA). AF488 was attached to,
respectively, each of the five Cys, generating five starting conformations
for simulated annealing using CNS. The models were initially minimized
with CNS (36,37) for 100 steps. To obtain good sampling of all possible
conformations, we implemented published methods involving a high-
temperature multitrial simulated annealing protocol with a slow cooling
schedule (40).
Each trial started with a cycle of six torsion-angle dynamics steps at
300,000 K, followed by cooling at a rate of 500 K per cycle. The integration
time step was 0.75 fs. The atomic coordinates are saved at the end of each
trial. The fluorescent probe, the Cys sulfur of attachment, and (depending
on labeling site) the side chains of 2–6 neighboring residues of FKBP,
were free to move while everything else in the model remained fixed. For
each probe location, 72 simulated-annealing calculations, each for 150 tri-
als, were run in parallel. Different initial velocities (obtained from a
random-number generator given a different seed value) and initial starting
conformations were used in each calculation to ensure different sampling of
the conformational space. The additional starting conformations were taken
from the resulting conformations of the first calculation. The simulations
produced a total of 10,800 conformations at each location. Data anal-
ysis—including calculation of the average probe position, root-mean-
square distance (RMSD), and order parameters—was carried out using
custom software we developed for this particular application. The volume
of the conformational space sampled was calculated using the VDW pro-
gram from the VOSSVOLVOX software package (https://code.google.
com/p/vossvolvox/) (41).Trilateration
The method of using distances to determine a location in space is termed
trilateration. Such methods have been previously described for macromo-
lecular complexes, e.g., the Nano-Positioning System developed by Mu-
schielok et al. (42) and Muschielok and Michaelis (43). Their method
was named based on similarity with the Global Positioning System, where
known satellite positions are used to determine an antenna location. From
the simulated-annealing calculations above, we obtained coordinates ofBiophysical Journal 107(9) 2037–2048
2040 Svensson et al.the average probe locations, which we are using as effective donor locations
for trilateration. We used effective AF488 locations calculated for the five
FKBP attachment sites (14, 32, 44, 49, and 85), and distances calculated
from FRET values as constraints, to determine a locus in space correspond-
ing to the acceptor attached to the N-terminus of DPc10.
We developed software that performs trilateration using an arbitrary
number of donor sites and distances. The method used was to identify
grid points on a three-dimensional grid that falls within a range defined
by the minimum and maximum distances (Rmin and Rmax, respectively)
calculated using Eq. 3 from the FRET measurement standard deviation
(SD) for each donor position. The SD-based distance ranges can be widened
symmetrically by a constant entered on the program command line. This
feature may be used, alternatively, to set a range centered at the average dis-
tance (Ravg) calculated from the average E. The spacing between the grid
points was 1 A˚. Inasmuch as in some cases there may not be a location
in space that satisfies all distance constraints, the software automatically
determined an acceptor location in space based on any combination of n,
n-1, and n-2 distances. The results were saved in PDB format, and were
also exported to a volumetric map after conversion via the program
PDB2VOL from the SITUS software package (http://situs.biomachina.
org/) (34). The trilateration software, is available from Bengt Svensson at
the University of Minnesota, Minneapolis, MN (http://ddt.umn.edu/).RESULTS
Determining the effective fluorophore locations
Our first goal was to determine, in silico, the effective loca-
tions of the FKBP-attached donor probes as accurately as
possible. Usually, the effective probe location is set at the
Ca or Cb atom of the labeled cysteine, or displaced from
the labeled cysteine by an arbitrary distance (44). That
may be grossly inaccurate for the Alexa Fluors, due to rela-
tively long linker chains between the fluorophore and reac-
tive moieties, as long as 21 A˚ for a fully extended linker. We
achieved more realistic predictions of the fluorophore loca-
tion using a computationally efficient simulated-annealing
method that utilizes short, high-temperature molecular dy-
namics (MD) simulations to sample the conformational
space, developed based on methods previously described
by Choi et al. (38) and Vrljic et al. (39).
To account for steric hindrance of the probe location due
to proximity to FKBP or RyR, we used the RyR1 cryo-EMFIGURE 2 (A) Cryo-EM map of RyR1 in the closed state (6), with the atomic
map was rotated as indicated to generate the views in panels B–D. (B) RyR1 map
removed. (C) Grid points of the map without the FKBP density were converted to
Dummy-atoms within 30 A˚ from FKBP are shown (red). (D) The atomic syste
dinates and the dummy atoms, which provide steric constraints corresponding t
Biophysical Journal 107(9) 2037–2048three-dimensional map to restrict the space that can be
sampled by the FKBP-attached AF488 (Fig. 2 A). For this,
we placed dummy atoms at the RyR1 map’s grid points in
the region surrounding FKBP. This was done by first dock-
ing the atomic structure of FKBP12 (31) into the cryo-EM
map corresponding to the RyR1 complex in closed confor-
mation (6) (Fig. 2 A). Then the map density corresponding
to FKBP was removed, inasmuch as that region would be
represented by the FKBP atomic coordinates (Fig. 2 B).
We then placed Ar atoms (inert atoms whose radii match
the cryo-EM map grid-point spacing) at grid points that
are proximal to FKBP and may directly come into contact
with FKBP residues or with the attached AF488 probes
(Fig. 2 C). The van der Waals radii of these atoms represent
the RyR protein volume and thus replace the cryo-EM map
to restrict the region sampled by the chromophore in our
simulations (Fig. 2 D).
Five variants of AF488-labeled FKBP were built by
substituting Cys at residues 14, 32, 44, 49, or 85 of FKBP,
and then attaching the AF488 probe to these sites by
molecular modeling. Running simulated-annealing using
the CNS software requires force-field parameters for the
fluorophore. Initial values of these parameters for AF488
were determined using XPLO2D, then manually optimized
before performing simulated-annealing calculations.
In previous reports, a few hundred trials/conformations of
the simulated-annealing were deemed sufficient to obtain
good conformational sampling (39). We initially ran five
simulations, each for 200 trials, with different initial veloc-
ities, to generate 1000 conformations. We observed that
after ~200–300 conformations we already had achieved
convergence to within ~1 A˚ RMSD of the 1000 conforma-
tion average. It was considered that an RMSD of <1 A˚
would provide sufficient precision for our purpose, when
compared with the SD typical for FRET.
To test whether sufficient sampling had occurred, addi-
tional simulations were conducted with different starting
conformations of AF488. Surprisingly, considering that
each of the five 200-trial runs with different initial velocitiesstructure of FKBP docked into the previously published location (14). This
with docked FKBP (blue ribbon). The density corresponding to FKBP was
Ar dummy-atoms using the VOL2PDB program (SITUS software package).
m used in the simulated annealing calculations consists of the FKBP coor-
o RyR. To see this figure in color, go online.
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FIGURE 3 Estimated average (squares) and maximum (dots) error in the
prediction of the average chromophore center position from the simulated-
annealing calculations, as shown by the RMSD distance to the average
position.
FRET Trilateration of DPc10 within Functional RyR2 2041all converged to within <1 A˚ RMSD, we observed that
simulations with different starting conformations did not
converge to the same average location. The discrepancy of
the average chromophore positions between different runs
was in the worst cases >10 A˚, depending on the labeling
site and starting conformation. The maximum variability
ranges seen in the results from different starting conforma-
tion simulations were similar. We concluded that different
starting configurations sample similar volumes in the
conformational space but with different density dis-
tributions. One might expect that a simulated-annealing
run with the MD portion starting at high temperature
(300,000 K) would quickly become degenerate and
completely sample the conformational space. However,
this is not what we observed.
To correct this problem, and find an average chromophore
position representing a complete sampling of the available
conformational space, we varied two parameters in the
simulation protocol:
1. We extended the number of trials per run and observed
that even when using as many as 3400 trials in a single
run, i.e., ~10 times more sampling than previously rec-
ommended (39), the average position of the chromo-
phore was similar to a 200-trial run with the same
starting conformation.
2. We ran simulations using combinations of the numbers
of trials per run and the number of different seeds each
generating 4800 conformations. These combinations
were: two simulations with different seeds run for
2400 trials, 12 simulations with different seeds run
for 400 trials, 16 simulations with different seeds run
for 300 trials, 24 simulations with different seeds
run for 200 trials, and 48 simulations with different
seeds run for 100 trials. The RMSD between the
average center positions of the chromophore was %
0.2 A˚ for all these cases. Based on these results, we
concluded that running simulations with the same start-
ing conformation with different seeds still gives a
possibly biased result.
To test whether our parameters for AF488 were the cause
of this unexpected behavior, we ran simulations where
the torsional-energy parameters for the linker had been
decreased 10-fold to 0.2 kcal/mol. Decreased torsional bar-
riers should allow the chromophore to sample the conforma-
tional space more efficiently and eliminate the apparent bias
associated with the starting conformation. However, the re-
sulting average chromophore position was still similar to
simulations run with the same starting conformation and
the higher torsional energy barriers (RMSD <0.2 A˚). We
concluded that the torsional-energy parameters did not
cause the bias. Furthermore, we ran simulations with the
Cy3 and Cy5 fluorescent probes, parameterized previously
(38,39), to test whether their starting conformations affected
the resulting average chromophore location. We arrived atthe same result as with AF488, i.e., different starting confor-
mations yielded different average chromophore locations.
Taken together, these results indicate that the simulated-
annealing procedure, as implemented in the CNS protocol
(39), is not sufficient to uniquely determine an average chro-
mophore position.
A possible way to correct this problem is to run multiple
trials with different starting conformations. To determine
how many starting conformations are needed before conver-
gence on an average position is achieved, we ran four inde-
pendent simulations with 12, 16, 24, and 48 starting
conformations, each generating 4800 conformations. We
found that the average position does converge toward one
position in space when increasing the number of starting
conformations. To determine how many calculations with
different starting conformations are needed to determine
the average location of the chromophore, we ran 103 calcu-
lations for each 150 trials. By randomly selecting a specific
number of calculations from this pool and calculating the
average position of that sample, we determined the average
and maximum RMSD error versus the average location
calculated from all 103 calculations (Fig. 3). As expected,
increasing the number of calculations with a different start-
ing conformation led to lowering the RMSD error. Consid-
ering the available computing resources and the queue time
limitations (<24 h wall time), as well as minimizing the
estimated error, we opted for 72 starting conformations
each run for 150 trials, generating 10,800 conformations
for the simulations on all labeling sites. The average and
maximum errors for this combination are 0.3 and 1.4 A˚,
respectively (Fig. 3).Effective positions of the FKBP-attached donors
Our simulated-annealing calculations show that the AF488
probe can adopt a wide range of conformations in theBiophysical Journal 107(9) 2037–2048
2042 Svensson et al.available space around the RyR-associated FKBP. For
FRET-based distance analysis and trilateration of accep-
tors bound to RyR, we need to determine the effective po-
sitions of the AF488 probe attached to position 14, 32, 44,
49, and 85 of FKBP. This was done by calculating the
average location of the chromophore from the simulated-
annealing calculations (Fig. 4). Results show effective
probe positions that are located 10–16 A˚ away from the
Ca atom of the labeled Cys (Table 1). The conformational
space sampled by the AF488 chromophore and average
positions corresponding to each attachment site are shown
in Fig. 4.
The volume sampled by AF488 depends on the labeling
site and is spatially restricted by both FKBP and RyR
(Table 1). The volume sampled by AF488 is >35,000 A˚3
at sites 14, 49 and 85, where little restriction from the
RyR is observed. AF488 at site 44 shows a slight (~20%)
reduction in the sampled volume due to spatial restriction
by the RyR map. AF488 at site 32 shows a large reduction
in its sampled volume (by >60%) because of steric restric-
tion due to the labeling site being located near an apparent
interface between FKBP and RyR. Even though the label
attached at position 32 appears to be more spatially
confined, we have shown that the binding of AF488-
FKBP to RyR is similar to unlabeled FKBP for all tested
labeling sites (15).Order parameters for AF488 attached to FKBP
The large number of possible conformations and large vol-
ume sampled by the AF488 probes suggest that the motion
of the probe is unrestricted, i.e., isotropic. This was quanti-
tatively analyzed based on the order parameters (S) derivedBiophysical Journal 107(9) 2037–2048from the simulated-annealing data (Table 1). S can be used
to describe how restricted the motion of the chromophore is,
and can be experimentally determined from fluorescence
anisotropy measurements. However, such measurements
are not possible in our system. Therefore, we estimated S
from the simulated annealing calculations, by determining
the orientation of the dipole vectors and calculating qeA,
the angle between the dipole vector of the chromophore in
each conformation and the mode vector. The mode vector
has the lowest sum of the great-circle distances to all other
vectors:
S ¼ 3 cos2qeA  12: (6)
In the wobble-in-a-cone model, S depends on the cone
angle, qc, according to
S ¼ 0:5 cos qcð1þ cos qcÞ; (7)
so qc can be expressed asqc ¼ a cos

ð0:25þ 2SÞ1=2  0:5
	
; (8)
S is nearly zero for donors attached at all the FKBP sites
used in this study (Table 1), thus indicating that all orienta-
tions are sampled, i.e., fluorophore dynamics is isotropic.
Although we cannot compare these results with experi-
mental fluorescence anisotropy data (which cannot be
measured in myocytes or isolated sarcoplasmic reticulum
samples, due to light scattering), the near-zero order param-
eter and wide cone-angles justifies the use of the orientation
factor k2 ¼ 2/3 for determining R0 according to Eq. 4. The
value k2¼ 2/3 is based on the assumption that the probes un-
dergo isotropic motion on a timescale that is short comparedFIGURE 4 Conformational distribution of
AF488 attached at specific FKBP sequence posi-
tions, as indicated. The conformational space
sampled by the fluorophore (red) was used to
calculate the coordinates of its average position
(green sphere). Average AF488 positions corre-
sponding to all FKBP labeling sites are shown
(orange, bottom right). To see this figure in color,
go online.
TABLE 1 Parameters from simulated-annealing calculations
of AF488 attached at Cys residues substituted within the FKBP
sequence
FKBP
labeling site Distance to Ca (A˚) Sampled volume (A˚
3) Sa qc
b
14 11.2 35,419 0.017 88.1
32 15.9 13,487 0.033 86.4
44 12.8 27,443 0.014 91.6
49 12.3 35,695 0.024 87.4
85 10.4 36,959 0.010 90.1
aDefined in Eq. 6.
bDefined in Eqs. 7 and 8.
FRET Trilateration of DPc10 within Functional RyR2 2043with the excited-state lifetime (several nanoseconds).
Considering that the acceptor fluorophores are attached to
their respective labeling sites via linkers similar in length
to the donors, they likely also have a low order parameter.
Therefore, our distance calculations from E assume random
orientation of fluorophores. Even if the acceptor is
completely immobilized, which is unlikely in practice, the
effect on k2 will result in a%10% error in the distance esti-
mation (45).Method validation using acceptor-labeled RyR
sites within the docked N-terminal ABC-domain
To test the computationally optimized donor coordinates
(Fig. 4), we used our previously published FRET-derived519500
181
76
519
500
76
181
76
181
A B
C D
FKBP
FKBP
181distances between D-FKBPs and the FRET acceptor
Cy3NTA (46) bound to His10 tags within the N-terminal
domain of RyR1 (27). We trilaterated the positions of
Cy3NTA targeted to His10 tags inserted at residues 76
(His10-76, domain A), 181 (His10-181, domain A), 500
(His10-500, domain C), and 519 (His10-519, domain C)
(Fig. 5). All four loci in the ABC-domain were identi-
fied using the procedure described in Materials and
Methods, which relies on FRET measurements from all
five D-FKBP constructs to each donor. For each FRET
measurement, we used Eq. 3, the average E, and corre-
sponding SD to calculate Ravg, Rmin, and Rmax. These
values are from Table 1 of Girgenrath et al. (27) for
His10-76, -181, and -519, and Table 2 of this article
for His10-500.
The distance ranges for His10-76 and -181 (Rmax–Rmin)
are relatively broad (averaging 15 and 18 A˚, respectively),
and their resulting loci are composed of many grid units
(represented as small spheres in Fig. 5, and see Fig. S1 in
the Supporting Material). Comparison of Fig. 5 in this
article and Fig. 5 from Girgenrath et al. (27) shows that
loci for Cy3NTA bound to His10-76 and His10-181 con-
structs are in similar locations. Fig. S1 depicts only the
His10-76 locus, without the overlapping larger volume of
the His10-181 locus that obscures it in Fig. 5. Both these
loci are slightly closer to FKBP than the corresponding
His10 insertion sites appear in the docked crystal structure
of the ABC-domain, and are located between their519
500
76 181
76
519
FIGURE 5 Trilaterated loci of Cy3NTA accep-
tors attached to His10 tags in the RyR1 N-terminal
domain. (A) RyR1 is viewed from cytosolic side.
Trilaterated acceptor positions are shown for
His10 inserted at positions 76 (purple) and 181 (yel-
low) in the A-domain (blue), and at positions 500
(gray sphere) and 519 (cyan sphere) in the C-
domain (red), relative to the RyR1 cryo-EM map
(EMDB:1606), the docked FKBP, and the docked
N-terminal ABC-domain, as indicated. Two adja-
cent ABC domains are represented, as indicated
by A, B, C, and A0, B0, C0 in their respective colors.
A vertical sectioning plane (dashed line) was used
to create the cut-out views in panels C and D. (B)
Magnified view of the region indicated in panel A
(dashed box). Trilaterated acceptor locations are
indicated in their respective color, whereas the
His10 insertion site locations are represented
(spheres) within the ABC-domain crystal structure
(black arrows and labels). Because residue 500 is
within a flexible loop that is not visible in the crys-
tal structure, we are indicating residue 499 instead.
(C) Cut-out view perpendicular to the plane indi-
cated in panel A. (Dark gray shading) Inside sur-
faces of the EM density revealed in cut-off. (D)
Magnified view of the region (dashed box) in panel
C. To see this figure in color, go online.
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TABLE 3 Confocal FRET measurements from FKBP-attached
AF488 donors to a DPc10-attached HF647 acceptor in
permeabilized cardiomyocytes
FKBP
labeling site E(photobleaching)a E(D quench)b
Ravg
(A˚)c
Rmin
(A˚)c
Rmax
(A˚)c
14 0.515 0.01 0.525 0.03 54 52 55
32 0.415 0.01 0.475 0.02 57 54 57
44 0.515 0.01 0.525 0.02 54 53 54
49 0.635 0.01 0.665 0.01 49 48 50
85 0.575 0.02 0.555 0.01 52 51 53
aE was calculated using Eq. 2.
bE was calculated using Eq. 1.
cDistances (R) were calculated using Eq. 3, as described in Materials and
Methods and Table 2.
TABLE 2 FRET E values and calculated distances between
D-FKBP and His10 inserted at RyR1 residue 500
FKBP
labeling
site
Predicted Ea,
site 500
Predicted Ea,
site 5000 Observed Eb
Ravg
(A˚)c
Rmin
(A˚)c
Rmax
(A˚)c
14 0.10 0.01 0.205 0.05(47) 75 71 79
32 0.94 0.02 0.695 0.05(9) 52 49 54
44 0.25 0.01 0.285 0.06(41) 70 66 73
49 0.19 0.02 0.245 0.06(34) 72 68 76
85 0.71 0.04 0.435 0.06(53) 62 59 64
aCalculated using Eq. 3, based on distances measured from the effective po-
sitions of the FKBP-attached donors to the His10 acceptor-insertion posi-
tions 500 and 5000 in domains C and C0, respectively, of two adjacent
RyR protomers (Fig. 5 A).
bObserved FRET efficiencies (means 5 SD, n indicated in parentheses)
were calculated from the increase in donor fluorescence after selective
acceptor photobleaching, using Eq. 2.
cDistances (R) were calculated using Eq. 3. The average distance (Ravg) was
calculated based on the average E. The minimum (Rmin) and maximum
(Rmax) distances were calculated based on the average E, to which we added
or subtracted the maximum SD of the measurement of E, respectively.
2044 Svensson et al.corresponding insertion points in the A- and A0-domains
(Fig. 5). This result may be due to comparable FRET contri-
butions from acceptor bound within both the A- and
A0-domain in the neighboring RyR protomers (27), as indi-
cated by arrows in Fig. 5 B. However, using the revised set
of donor coordinates, we obtained smaller loci (1300 vs.
5200 A˚3 for the His10-76 site, and 16,900 vs. 25,000 A˚3
for the His10-181 site), thus confirming our prediction of
improved precision.
The locus for Cy3NTA attached at His10-519 was also
determined based on previously reported FRET results
(27). However, the FRET measurement SD translated into
50% narrower distance ranges than for His10-76 and -181,
and yielded a locus only upon a slight broadening of these
ranges (by 1.7 A˚). This locus consists of a single grid unit
(indicated by a single sphere in Fig. 5, B andD) that is found
in a void near domain C, 23 A˚ from the insertion site at res-
idue 519. This location is consistent with the predicted cyto-
solic exposure of the insertion site. Upon further broadening
of the distance ranges, this locus would gradually expand in
this void, away from theHis10 insertion site. As predicted, for
the locus of Cy3NTA attached to site 519 there is no evidence
of FRET contribution from multiple acceptors, by compari-
son with the trilaterations of sites 76 and 181 above. This pre-
cision and apparent accuracy seemed quite remarkable.
To further test the consistency of this method, we trilater-
ated Cy3NTA attached at His10-500, also in domain C. For
this site also, we observed good consistency between the
profiles of predicted and measured FRET from D-FKBP
(Table 2). FRET measurement SDs for the 500 locus were
similar to those observed for 519, and also needed to be
slightly broadened (by 1.3 A˚) to yield a locus, which con-
sisted of a single grid unit. This was 27 A˚ from the His10
insertion site, in the same void of the RyR1 map as the locus
corresponding to the 519 insertion site (Fig. 5, B andD). TheBiophysical Journal 107(9) 2037–2048offsets between the 500 and 519 acceptor loci and their pre-
dicted attachment site locations are consistent with the
length of the linker between the Cy3 fluorophore and the
NTA moiety.
Therefore, we conclude that the revised donor coordi-
nates provide significantly improved precision and accuracy
versus donor positions set at the Cb coordinates.Trilateration of acceptor-labeled DPc10 bound to
RyR2, based on confocal FRET measurements in
permeabilized cardiomyocytes
Using confocal FRET measurements in permeabilized car-
diomyocytes, we have previously determined that the
acceptor probe covalently linked to the N-terminus of
DPc10 may localize along a broad arc intersecting RyR
domain 3 between FKBP and CaM (26). In that study,
FRET was measured only from D14-FKBP to A-DPc10,
and the result was further constrained using FRET between
CaM and DPc10 (26). Here, we aimed to resolve a discrete
location of the A-DPc10 probe using FRET measurements
from each of our five donor-labeled FKBP variants to the
same acceptor-labeled DPc10 bound to RyR2, in permeabi-
lized rat cardiomyocytes. FRET efficiencies, E, were
measured using two methods—acceptor photobleach and
donor quench—with highly consistent results, summarized
in Table 3. All FRET measurements were carried out under
conditions that saturate the DPc10 binding sites ([F-
DPc10] ¼ 5 mM), as shown before in Oda et al. (26).
Measured FRET efficiencies ranged between 0.4 and 0.7,
which is well within the quasi-linear range of the R-
versus-E relationship (Eq. 1).
To determine the DPc10 binding site location, we used a
cryo-EM map of RyR1, which has been solved to a much
higher resolution than RyR2 (10.2 vs. ~30 A˚). This
approach is based on the assumption that the RyR1 and
RyR2 channel isoforms have similar overall structures and
features (47,48), as has been revealed by cryo-EM image re-
constructions of comparable resolution (~30 A˚) and by crys-
tal structures of isolated soluble RyR fragments (10,49).
Using FRET, we have previously shown that FKBP12.0
FRET Trilateration of DPc10 within Functional RyR2 2045and 12.6 bind at equivalent sites (16), and in the same orien-
tation within the RyR1 and RyR2 complexes (15).
A-DPc10 loci were calculated based on all five FRET-
derived distances between the D-FKBP variants and
A-DPc10, and for all five sets of four FRET-derived dis-
tances. Solutions were constrained by the RyR1 cryo-EM
map, by the CaM N- and C-domain locations previously
determined within RyR1 (Fig. 6, A and B) from FRET mea-
surements and the cryo-EM map of the CaM-RyR1 complex
(13,15,29), and by the FRET-derived distances between
D34-CaM or D110-CaM and A-DPc10 (63 5 1 and 53 5
1 A˚, respectively) (26).
The five-distance trilateration of DPc10 yielded a locus
only after widening the Rmax-Rmin range by 14 A˚, but this
locus is ~40 A˚ away from the surface of the RyR cryo-
EM map, and therefore this is not a possible solution (see
Fig. S2). Multiple loci were found based on different com-
binations of four distances. The loci found by excluding
the measurements from donor attached at FKBP sites 14,
49, or 85 were implausible solutions because they were
>25 A˚ away from the cryo-EMmap surface and also incom-
patible with the CaM-lobe placements (see Fig. S2). The lo-
cus found by excluding the measurement from donor at
FKBP position 32 was found within domain 9 of the
RyR1 cryo-EM map (see Fig. S2). However, that location
was incompatible with the FRET measurements fromCaM-attached donors to A-DPc10 (26). Only the set of dis-
tances from donors at FKBP residues 14, 32, 49, and 85 (44
was excluded) yielded a solution that was acceptable when
constrained by the cryo-EM map (Fig. 6).
This A-DPc10 locus was found within RyR domain 3
(Fig. 6, magenta shading), the large handle density that con-
nects the FKBP and CaM binding sites. The distance be-
tween this locus and D34-CaM is R1 ¼ 60 A˚ (Fig. 6, A
and B), which matches well with the 63 5 1 A˚ calculated
from FRET (26). Distances between the A-DPc10 locus
and the D110-CaM on the same and adjacent faces of the
RyR1 map are R2 ¼ 81 A˚ and R20 ¼ 76 A˚, respectively,
which are significantly different from the apparent distance
derived from FRET (535 1 A˚). This inconsistency is likely
due to a higher uncertainty in the C-lobe placement (versus
N-lobe). The relationship among this buried A-DPc10 locus,
FRET distance analysis (including from donor bound to
CaM’s C-domain), and the RyR2 location of CaM proposed
by Huang et al. (50), is further analyzed in the Discussion.DISCUSSION
Trilateration method development
We have developed a trilateration method that uses spectro-
scopic distance measurements from an ensemble of probesFIGURE 6 Location of HF647 attached to
DPc10 bound to RyR2. (A) RyR1 viewed from
the cytosolic side. The trilaterated position of the
DPc10-attached acceptor is shown (magenta
within black-dotted oval) relative to the cryo-EM
structure of the closed RyR1 (EMDB:1606), the
docked FKBP, the docked RyR ABC-domain,
and the predicted locations of the CaM N- and
C-lobes, as indicated (13). Distances between A-
DPc10 and the N- and C-lobe of CaM on the
same face of RyR are indicated by R1 and R2. R2
0
indicates the distance between DPc10 and the
C-lobe of CaM bound on adjacent faces of RyR.
A vertical sectioning plane (dashed line) was
used to create the cut-out views in C and D. (B)
RyR1 is shown in side view. The trilaterated posi-
tion of the DPc10-attached acceptor (dotted oval)
was found in RyR domain 3 (the handle). A second
solution generated by the same distances is on the
opposite side of FKBP, well outside the cryo-EM
map (red x). (C) Cut-out view perpendicular to
the plane indicated in panel A. (Dark gray shading)
Inside surfaces of the EM map revealed in cut-off.
(D) Magnified view of the region (dashed box) in
panel C. The distance of nearest approach between
the C-domain (at residue 455) and the A-DPc10
locus (magenta) is R3 ¼ 35 A˚. A gallery that com-
municates with the cytosol (dotted yellow oval) al-
lows DPc10 access to space around domain C,
where it may perturb an interface (magenta
shading) formed between the lower tip of the C-
domain and a noncontiguous RyR domain. To
see this figure in color, go online.
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2046 Svensson et al.placed at known locations within a three-dimensional pro-
tein structure to a probe bound at an unknown location,
aiming to determine its three-dimensional location. We pre-
viously used the Cb coordinates of the labeled Cys residue to
place the known-location probes. That method does not take
into account the linker between the labeling site and the flu-
orophore itself. To more accurately estimate the effective
probe location, and improve the precision of trilateration,
we developed a simulated-annealing protocol designed to
determine the space occupied by all probe conformations,
and determine the average probe position. We started from
an existing computational-annealing protocol (39) and
developed additional steps to minimize the potential depen-
dence in the final average position on the starting conforma-
tion. We determined that this major source of error in probe
placement can be almost completely eliminated by aver-
aging the results from as many simulated annealing calcula-
tions as practically afforded by the computational resources.
Based on queue time limitations, we chose to average the
results from 72 annealing calculations using different
starting conformations, which results in acceptable pre-
dicted RMSD error (0.3 A˚ average, 1.4 A˚ maximum error;
Fig. 3).Calculated donor positions improve trilateration
precision
We used this simulated-annealing protocol to determine the
average locations of AF488 probes covalently bound to
several Cys residues substituted at surface sites of FKBP
(Fig. 4), chosen to be away from the RyR-FKBP binding
interface, such that their chemical modification would not
interfere with binding. Analysis of the simulated-annealing
data indicates that there is little steric restriction of the
probes by either the RyR or FKBP, so fluorophore MD
can be assumed to be almost completely isotropic (Table 1).
This justifies using k2 ¼ 2/3 for distance calculations based
on FRET data, thereby facilitating conversion to donor-
acceptor distances from the measured FRET efficiencies.
We found that the calculated effective location of the
AF488 fluorophore moiety can be relatively far (10–16 A˚)
from the Cb, which can potentially affect the trilateration
result. These calculated fluorophore positions present the
advantage that they are more broadly separated in space
(than when set at the Cb atoms), so we predicted that this
spatial expansion of the reference-probe set would signifi-
cantly improve the precision of trilateration. This is what
we actually observed for the acceptors attached at known
locations in the ABC domain—in all cases, the believed-
new trilateration method yielded smaller loci than our previ-
ous method. The smallest and most plausibly positioned loci
were obtained when the acceptor attachment sites were in
the RyR1 C-domain, which is the farthest from the channel’s
axis of symmetry, and thus least affected by FRET cross-
talk between adjacent RyR protomers (Fig. 5). Nevertheless,Biophysical Journal 107(9) 2037–2048the general trilateration locations for the ABC domain
acceptor attachment sites were similar between the previ-
ously used Cb (27) and the computed effective coordinates
of the donor probes used here.DPc10 locus relative to RyR structural features
revealed by the cryo-EM map
Having validated our improved trilateration method, we
then used it to determine the location of an acceptor probe
attached to DPc10 bound to RyR2 based on FRET measure-
ments carried out in permeabilized myocytes (Table 3). It
has been postulated that DPc10 directly competes with in-
tersubunit contacts (51) between the RyR2 N- and central
domains (zipping) by binding to the N-domain sequence
(to unzip) (18). Taken literally, this model implies that
DPc10 should bind in close proximity to the N-domain
zipping surface. Because DPc10 is related to the RyR1-
derived peptide DP4 (18), both probes may bind at equiva-
lent three-dimensional locations within RyR1 and RyR2.
Our FRET-based trilateration results indicate that A-
DPc10 is deep within RyR domain 3 (which forms the
handle domains in the cryo-EM map). This buried location
of the A-DPc10 probe is consistent with the previous finding
that DPc10 access to its RyR2 binding site is sterically
restricted and under negative allosteric control by CaM
(26). To place the acceptor at that location, DPc10 may
bind to domain 3 on its distal face relative to the fourfold
axis of symmetry of RyR. In this placement, direct contact
between DPc10 and the centrally located ABC domain
can be ruled out. This model is plausible but incompatible
with the prevalent version of the domain zipping model
(52). Alternatively, DPc10 may bind to the proximal face
of domain 3 by diffusing through a wide gallery formed be-
tween peripheral RyR domains (i.e., 3, 8, 9, and 10) and
more central domains (i.e., 2 and 4).
Indeed, the DPc10 locus is nearest (~35 A˚) to residue
Pro455 in the RyR1 C domain (R3 in Fig. 6 D). Assuming
that RyR2-bound DPc10 adopts the predicted compact
structure (Fig. 1, ~25 A˚ diameter) and that acceptor might
be situated ~12 A˚ from its N-terminal attachment site, it is
possible that DPc10 can lodge in the cytosol-accessible
gallery separating domains C and 3 (Fig. 6 D, yellow
oval). Here, it may perturb an apparent interface (Fig. 6
D, magenta shading) between the RyR C domain and the
densities (columns) that connect the large RyR cytoplasmic
domain to the TM domain, which contains the channel pore.
Thus, the DPc10 binding site may be at the convergence of
structural pathways transducing regulatory gating signals
from the RyR cytosolic headpiece to the channel pore
in the TM domain. Mutations or posttranslational modifica-
tions (oxidation, phosphorylation) associated with pathol-
ogies may structurally alter one or more of these
pathways, thus leading to a more accessible DPc10 binding
site (domain unzipping), as observed for arrhythmia-linked
FRET Trilateration of DPc10 within Functional RyR2 2047leaky RyR2 mutants (20), or WT-RyR2 from animal models
of heart failure (22,52).Relationship between the A-DPc10 locus and the
N- and C-lobes of CaM
Two FRET measurements from CaM-attached donors to
A-DPc10 are available (26)—from AF488 attached at
CaM position 34 (N-lobe), and from AF568 attached at
CaM position 110 (C-lobe). Distances derived from these
measurements are 63 5 1 A˚ and 53 5 1 A˚, respectively.
The distance R1 ¼ 61 A˚ (Fig. 6, A and B) between the A-
DPc10 locus and the previously determined location of
CaM’s N-lobe (13) is consistent with the FRET measure-
ment. However, the distance R2¼ 81 A˚ (Fig. 6, A and B) be-
tween the A-DPc10 locus and the C-lobe location (13) on
the same face of RyR, is inconsistent with the corresponding
FRET measurement. This discrepancy may be due to DPc10
altering the structure of RyR2-bound CaM (and there may
be a reciprocal effect).
Alternatively, this apparent discrepancy may be due to
CaM binding to RyR2 in an extended conformation, with
the C-lobe projecting deep into the groove formed between
domains 3 and 8 (Fig. 6, A and B). This would place the
donor attached at CaM residue 110 nearer the A-DPc10
locus in the adjacent RyR protomer (R2
0 in Fig. 6, A
and B). This is consistent with the mapping of Ca2þ-CaM
(inhibitory in both RyR1 and RyR2) within RyR1 (53).
This placement of the C-lobe-attached donor does not
contradict the results reported by Huang et al. (50), who
noted in their detailed cryo-EM analysis of CaM binding
to RyR2 versus RyR1 that the mass corresponding to
Ca2þ-CaM bound to RyR2 was weaker than expected, sug-
gesting that a significant portion of CaM was not visible in
their cryo-EM map, possibly due to structural disorder.
More detailed determinations of the RyR-bound CaM struc-
ture will be the focus of future studies.Perspective
The multiscale mapping process demonstrated in this article
enables resolving sequence locations and binding sites
throughout most of the RyR structure, and thus should
further our understanding of the structure-function correla-
tions of this channel. Determining the binding locations of
A-DPc10 and other peptide-based biosensors of the RyR
functional state may provide a rational basis to design
probes necessary for diagnostic and therapeutic discovery
targeting the RyR pathological leak, which represents an
important unmet health need (54).SUPPORTING MATERIAL
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